Risks and benefits of weight loss: Challenges to obesity research

European Heart Journal, Supplement

Volumn 7, Issue L, 2005, Pages

  Ryan, Donna ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Cholesterol; Look AHEAD; Mortality; Obesity; Outcome trial; SCOUT; Weight loss

Indexed keywords

CARDIOVASCULAR RISK; CONFERENCE PAPER; MORTALITY; OBESITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; WEIGHT REDUCTION;

EID: 27744506962     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sui083     Document Type: Conference Paper

References (12)

1. Gray DS. Diagnosis and prevalence of obesity. Med Clin North Am 1989;73:1-13.
2. Lavie CJ, Mehra MR, Milani RV. Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 2005;26:5-7.
3. Horwich TB, Fonarow GC, Hamilton MA et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001;38:789-795.
4. Anker SD, Negassa A, Coats AJ et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin- converting-enzyme inhibitors: an observational study. Lancet 2003;361:1077-1083.
5. Higgins M, D'Agostino R, Kannel W et al. Benefits and adverse effects of weight loss. Observations from the Framingham Study. Ann Intern Med 1993;119:758-763.
6. Williamson DF, Thompson TJ, Thun M et al. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000;23:1499-1504.
7. Van Gaal L. What is the relationship between risk factor reduction and degree of weight loss? Eur Heart J Suppl 2005;7:L21-26.
8. Tuomilehto J, Lindstrom J, Eriksson JG et al.; Finnish Diabetes Prevention Study Group. Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
9. Knowler WC, Barrett-Connor E, Fowler SE et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
10. Sjöström L, Lindroos AK, Peltonen M et al.; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-2693.
11. James WPT. The SCOUT study: risk-benefit profile of sibutramine in overweight high risk cardiovascular patients. Eur Heart J Suppl 2005;7:L44-48.
12. Ryan DH, Espeland MA, Foster GD et al.; Look AHEAD Research Group. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in Type 2 diabetes. Control Clin Trials 2003;24:610-628.